CORD-19:c654596857bce9cdd64ffc51842048643107348c / 60519-60838 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T480","span":{"begin":0,"end":319},"obj":"Sentence"},{"id":"T85741","span":{"begin":0,"end":319},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"From 1997 to 2001 , 1058 Our retrospective study results support previous pharmaco-economic considerations according which in choosing an antibiotic regimen for AE-COPD we must take into consideration the expected clinical and microbiological results without forgetting to consider the economic burden of our decisions."}

{"project":"Epistemic_Statements","denotations":[{"id":"T102","span":{"begin":0,"end":319},"obj":"Epistemic_statement"}],"text":"From 1997 to 2001 , 1058 Our retrospective study results support previous pharmaco-economic considerations according which in choosing an antibiotic regimen for AE-COPD we must take into consideration the expected clinical and microbiological results without forgetting to consider the economic burden of our decisions."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T76","span":{"begin":0,"end":319},"obj":"Sentence"}],"text":"From 1997 to 2001 , 1058 Our retrospective study results support previous pharmaco-economic considerations according which in choosing an antibiotic regimen for AE-COPD we must take into consideration the expected clinical and microbiological results without forgetting to consider the economic burden of our decisions."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T46","span":{"begin":164,"end":168},"obj":"Phenotype"}],"attributes":[{"id":"A46","pred":"hp_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/HP_0006510"}],"text":"From 1997 to 2001 , 1058 Our retrospective study results support previous pharmaco-economic considerations according which in choosing an antibiotic regimen for AE-COPD we must take into consideration the expected clinical and microbiological results without forgetting to consider the economic burden of our decisions."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T192","span":{"begin":161,"end":163},"obj":"Disease"},{"id":"T193","span":{"begin":164,"end":168},"obj":"Disease"},{"id":"T64130","span":{"begin":161,"end":163},"obj":"Disease"},{"id":"T43567","span":{"begin":164,"end":168},"obj":"Disease"}],"attributes":[{"id":"A192","pred":"mondo_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/MONDO_0017282"},{"id":"A193","pred":"mondo_id","subj":"T193","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A16785","pred":"mondo_id","subj":"T64130","obj":"http://purl.obolibrary.org/obo/MONDO_0017282"},{"id":"A6450","pred":"mondo_id","subj":"T43567","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"}],"text":"From 1997 to 2001 , 1058 Our retrospective study results support previous pharmaco-economic considerations according which in choosing an antibiotic regimen for AE-COPD we must take into consideration the expected clinical and microbiological results without forgetting to consider the economic burden of our decisions."}